Research led by UQ has found COVID-19 activates the same inflammatory response in the brain as Parkinson’s disease.
1 November 2022
For the first time, researchers have identified key molecules within the immune system that may help fight the inflammation that drives chronic diseases including cancers, sepsis and brain disease.
28 September 2021Important research projects addressing challenges from skin cancer to traffic injuries at The University of Queensland have been awarded more than $50 million from the Australian Government.
16 September 2021
A potential therapy developed at The University of Queensland may one day save lives by helping patients recover faster from severe trauma, extensive burns and major surgery.
13 July 2021
Customised immune-blocking medication may be the key to treating patients with motor neurone disease (MND), which currently has no cure and limited therapeutic options.
17 February 2020
A red vintage truck named ‘Roxy’ is helping drive research to find a cure for motor neurone disease.
18 April 2019
Inflazome, a biotech company developing new drugs to block harmful inflammation, has secured further investment of $63 million.
28 November 2018
A promising new therapy to stop Parkinson’s disease in its tracks has been developed at The University of Queensland.
1 November 2018
The world’s next big medical breakthroughs could be in the hands of four University of Queensland researchers, announced as National Health and Medical Research Council Development Grant recipients.
29 August 2018
Challenges of a modern Australia – ranging from melanoma, to termites, to degenerative disorders, reef protection and food provision – are in the sights of six UQ projects to share $4.2 million in State Government funding.
20 October 2017
A record number of researchers and research supervisors has been honoured for their outstanding achievements at the 2017 UQ Research Week awards.
13 September 2017
Three University of Queensland researchers have each received $1 million from the FightMND foundation for clinical trials to help fast-track potential treatments for motor neurone disease.
9 June 2017
A clinical-stage biotechnology company established by The University of Queensland and Emory University (Atlanta, USA) to develop novel cancer supportive care and anticancer therapies has raised US$16 million in series A investment.
6 June 2017
Researchers say a protein usually associated with the immune system could play a role in the development of neurological conditions such as epilepsy and schizophrenia.
19 May 2017
A drug with the potential to delay the progression of motor neuron disease (MND) could be in human trials within three years.
27 March 2017.jpg?itok=4Tu7RWbT)
Researchers have unlocked secrets of our ancient immune system in a major scientific advance that could help scientists and clinicians in the global fight against disease.
24 June 2016
Queensland researchers have discovered that the first-stage response of the immune system can contribute to melanoma, colon and breast cancer growth, rather than helping the body to fight it.
14 June 2016
A University of Queensland research team has been awarded a grant from The Michael J. Fox Foundation for Parkinson’s Research to target brain inflammation in people with Parkinson’s disease.
6 March 2015
Australia’s first Centre of Research Excellence in Chronic Kidney Disease will be established at The University of Queensland with a $2.5 million grant announced today.
17 October 2014A University of Queensland researcher has been recognised as a future leader in medical research for his groundbreaking work on understanding the biological basis of disease to develop new treatment options.
21 June 2013- 1 of 2
- next ›
